Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Guo

Showing results (771-780 of 843) with videos related to

Pageof 85
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group studyJ M Maris, M J Weiss, C Guo, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|February 22, 2020
[Risk assessment of exported risk of COVID-19 from Hubei Province]J X Hu, G H He, T Liu, et al.
The Journal of Urology|September 25, 2016
Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future DirectionGrant P Redrow, Charles C Guo, Maurizio A Brausi, et al.
Medical and Pediatric Oncology|July 24, 2001
Detailed molecular analysis of 1p36 in neuroblastomaP S White, P M Thompson, B A Seifried, et al.
Epilepsy Research|April 5, 2011
Deletion of the betaine-GABA transporter (BGT1; slc6a12) gene does not affect seizure thresholds of adult miceA C Lehre, N M Rowley, Y Zhou, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|July 6, 2025
[Comparison of magnetic resonance images of the temporomandibular joint using different coils]X J Zhang, T T Wu, Y Zhang, et al.
ESMO Open|April 19, 2024
A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutationsJ Rodon, E Rodriguez, M L Maitland, et al.
Clinical Genetics|December 2, 2015
Pathogenic FBN1 variants in familial thoracic aortic aneurysms and dissectionsE S Regalado, D C Guo, R L P Santos-Cortez, et al.
BJU International|February 22, 2011
Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma CollaborationRamy F Youssef, Shahrokh F Shariat, Yair Lotan, et al.
Public Health|July 10, 2021
Adherence to antihypertensive medications for secondary prevention of cardiovascular disease events: a dose-response meta-analysisY Feng, M Han, R Qie, et al.
Pageof 85

Showing results (771-780 of 843) with videos related to

Sort By:
Pageof 85
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group studyJ M Maris, M J Weiss, C Guo, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|February 22, 2020
[Risk assessment of exported risk of COVID-19 from Hubei Province]J X Hu, G H He, T Liu, et al.
The Journal of Urology|September 25, 2016
Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future DirectionGrant P Redrow, Charles C Guo, Maurizio A Brausi, et al.
Medical and Pediatric Oncology|July 24, 2001
Detailed molecular analysis of 1p36 in neuroblastomaP S White, P M Thompson, B A Seifried, et al.
Epilepsy Research|April 5, 2011
Deletion of the betaine-GABA transporter (BGT1; slc6a12) gene does not affect seizure thresholds of adult miceA C Lehre, N M Rowley, Y Zhou, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|July 6, 2025
[Comparison of magnetic resonance images of the temporomandibular joint using different coils]X J Zhang, T T Wu, Y Zhang, et al.
ESMO Open|April 19, 2024
A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutationsJ Rodon, E Rodriguez, M L Maitland, et al.
Clinical Genetics|December 2, 2015
Pathogenic FBN1 variants in familial thoracic aortic aneurysms and dissectionsE S Regalado, D C Guo, R L P Santos-Cortez, et al.
BJU International|February 22, 2011
Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma CollaborationRamy F Youssef, Shahrokh F Shariat, Yair Lotan, et al.
Public Health|July 10, 2021
Adherence to antihypertensive medications for secondary prevention of cardiovascular disease events: a dose-response meta-analysisY Feng, M Han, R Qie, et al.
Pageof 85